ANIK 8-K 2026-01-08

Anika Therapeutics, Inc. (ANIK) 8-K dated 2026-01-08 — accession 0001193125-26-007655. This URL is the filing, not the ANIK hub.

Anika Therapeutics, Inc. (ANIK) is a drug manufacturers - specialty & generic company listed on US.

Anika Therapeutics, Inc. filed a 8-K on 2026-01-08. Accession 0001193125-26-007655.

Cached items: 2.02, 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.

Not investment advice. The ANIK SEC hub lists recent forms. The stock page is the research view.